APA (7th ed.) Citation

Kosmeri, C., Baltogianni, M., Giapros, V., Siomou, E., Tsinopoulou, V., Balomenou, F., & Serbis, A. (2024). Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients. Endocrines, 5(2), 214. https://doi.org/10.3390/endocrines5020015

Chicago Style (17th ed.) Citation

Kosmeri, Chrysoula, Maria Baltogianni, Vasileios Giapros, Ekaterini Siomou, Vasiliki-Regina Tsinopoulou, Foteini Balomenou, and Anastasios Serbis. "Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients." Endocrines 5, no. 2 (2024): 214. https://doi.org/10.3390/endocrines5020015.

MLA (9th ed.) Citation

Kosmeri, Chrysoula, et al. "Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients." Endocrines, vol. 5, no. 2, 2024, p. 214, https://doi.org/10.3390/endocrines5020015.